Bach L A, Thotakura N R, Rechler M M
Growth and Development Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.
Biochem Biophys Res Commun. 1992 Jul 15;186(1):301-7. doi: 10.1016/s0006-291x(05)80807-1.
Insulin-like growth factor binding protein-6 is abundant in cerebrospinal fluid and has a marked preferential binding affinity for IGF-II over IGF-I. The present study demonstrates that IGFBP-6 is O-glycosylated but not N-glycosylated. Carbohydrate analysis revealed the presence of approximately 20-30 carbohydrate residues/molecule. Galactosamine, galactose and sialic acid were most abundant, with glucosamine and fucose present in lower concentrations. Mannose was not detected. Enzymatic deglycosylation did not alter the high affinity of IGF binding protein-6 for IGF-II (Ka 4.4 +/- 2.2 x 10(11) M-1) or its preference for IGF-II over IGF-I. Glycosylation of IGFBP-6 may affect its secretion, in vivo stability or localization, but does not affect its ligand binding properties.
胰岛素样生长因子结合蛋白-6在脑脊液中含量丰富,对胰岛素样生长因子-II(IGF-II)的结合亲和力明显高于胰岛素样生长因子-I(IGF-I)。本研究表明,胰岛素样生长因子结合蛋白-6是O-糖基化的,而非N-糖基化。碳水化合物分析显示,每个分子中约有20 - 30个碳水化合物残基。半乳糖胺、半乳糖和唾液酸含量最为丰富,氨基葡萄糖和岩藻糖含量较低。未检测到甘露糖。酶促去糖基化并未改变胰岛素样生长因子结合蛋白-6对IGF-II的高亲和力(Ka 4.4 +/- 2.2 x 10(11) M-1)及其对IGF-II相对于IGF-I的偏好性。胰岛素样生长因子结合蛋白-6的糖基化可能影响其分泌、体内稳定性或定位,但不影响其配体结合特性。